There’s More To Syngene Stock Surge Than Remdesivir Supply Pact
A man walks past an electronic stock board displaying a graph. (Photographer: Tomohiro Ohsumi/Bloomberg)

There’s More To Syngene Stock Surge Than Remdesivir Supply Pact

Shares of Syngene International Ltd. have surged nearly threefold in the last six months, beating all benchmarks and peers, as the contract researcher signed pacts to make a drug used in severe cas...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.